Afleveringen
-
In 1891, a young surgeon named William Coley watched a teenage patient die of sarcoma and couldn't let it go. He went looking for a man who had supposedly beaten the same disease after contracting a severe bacterial infection — and found him, cancer-free, in a tenement on the Lower East Side of Manhattan. What followed was forty years of documented tumor regressions, fierce institutional resistance, and a treatment that was ultimately buried by the rise of radiation and chemotherapy. This episode traces how Coley stumbled onto the foundational principle of cancer immunotherapy a century before medicine had the language to understand it — and how his daughter, with no scientific training and a $2,000 loan, kept the idea alive long enough for the rest of medicine to catch up. For the full written case file, visit thepharmafiles.substack.com.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com -
In 1927, a wealthy Pittsburgh socialite injured his arm on a train and was handed a bottle of certified radioactive water as a remedy. He drank it daily for three years — eventually consuming somewhere between 1,000 and 1,500 bottles. By 1931, his bones were dissolving from the inside. This episode traces how radium went from Nobel Prize-winning discovery to prestige wellness product, how an unlicensed fraudster bottled it and sold it to the American elite, and why the people drinking it weren’t foolish — they were simply living in a moment when radiation seemed like the future, and nobody had yet learned what the future cost. For the full written case file, visit thepharmafiles.substack.com.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com -
Zijn er afleveringen die ontbreken?
-
In 1992, a businessman published a book called Sharks Don’t Get Cancer — and overnight, a legitimate line of Harvard and MIT cancer research became the justification for a multimillion-dollar supplement industry. This episode traces how real science, carefully caveated by the researchers who produced it, got stripped of its caveats, tested on desperate patients without controls, and sold in health stores across America before a single properly designed trial had been run. For the full written case file, visit thepharmafiles.substack.com.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com -
In the 1840s, a product called Mrs. Winslow's Soothing Syrup became one of the best-selling medicines in America and Britain — promising exhausted parents relief from teething, colic, and fretfulness. It delivered, every time, because it contained morphine. This episode traces how an entire industry built fortunes on narcotic sedation in infants by wrapping it in the image of a kindly grandmother and a label full of reassuring language — and how it took six decades, a muckraking journalism campaign, and an act of Congress before anyone was legally required to say what was actually in the bottle. For the full written case file, visit thepharmafiles.substack.com.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com -
In the 1920s, Nobel laureate Otto Warburg observed that cancer cells metabolize glucose differently — a real finding now used in PET scans worldwide. But his leap to conclude that cancer is caused by oxygen deprivation sparked a century of misapplied science. This episode traces how ozone therapy — from Tesla-branded generators to blood-ozonation clinics — exploited that misreading, offering a visually compelling treatment to desperate patients despite documented deaths, no rigorous trials, and a 1976 FDA declaration that ozone has no known useful medical application. For the full written case file, visit thepharmafiles.substack.com.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com -
In the early 20th century, as tuberculosis ravaged populations and effective treatments remained out of reach, physicians turned to a seemingly simple intervention: the “milk cure.” By prescribing patients three to four quarts of milk daily alongside rest and fresh air, doctors aimed to rebuild the body and slow the disease’s relentless progression. The approach gained widespread acceptance in sanatoriums, bolstered by visible improvements like weight gain and restored energy. But these gains often reflected the broader care environment rather than the milk itself. This episode explores how nutritional therapy became a stand-in for causation, why a lack of rigorous evidence allowed belief to flourish, and what the rise and quiet fall of the milk cure reveals about medicine’s enduring tendency to over-attribute success to the most visible intervention.
For the full written case file, visit thepharmafiles.substack.com.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com -
In the 1930s, inventor Royal Raymond Rife claimed he had discovered a revolutionary way to treat disease: by identifying the unique electromagnetic frequencies of microorganisms and destroying them with precisely tuned energy. Using a custom-built microscope and a plasma device known as the Rife Machine, he proposed a vision of medicine without drugs or surgery—where illness could be eliminated through resonance alone. Early reports of cancer cures spread through anecdote rather than evidence, captivating patients and fueling belief in a breakthrough just beyond scientific reach. This episode explores how the Rife Machine blurred the line between innovation and illusion, why its claims collapsed under scrutiny, and what its enduring appeal reveals about medicine’s promise—and the human desire for simple, invisible solutions to complex disease.
For the full written case file, visit thepharmafiles.substack.com.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com -
In the 1930s, psychiatrists searching for answers to schizophrenia embraced a radical intervention: insulin coma therapy. By deliberately driving patients into deep hypoglycemic coma—sometimes daily for weeks—physicians believed they could “reset” the brain and disrupt psychosis. Hospitals built specialized insulin wards, and the treatment quickly became standard care despite thin evidence and significant risk. This episode explores how a dangerous shock therapy came to symbolize modern psychiatry, why dramatic case reports overshadowed missing data, and what insulin coma therapy reveals about medicine’s tendency to mistake intensity for effectiveness.
For the full written case file, visit thepharmafiles.substack.com.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com -
In the 1920s, physician Max Gerson proposed a radical idea: cancer was not a genetic disease, but a metabolic one—driven by toxins, nutritional imbalance, and a failing liver. His therapy promised healing through strict diet, intensive juicing, supplements, and controversial coffee enemas, offering hope to patients wary of conventional treatment. This episode explores how the Gerson Therapy captured nearly a century of devotion and skepticism, why anecdote clashed with evidence, and what its persistence reveals about control, belief, and the enduring appeal of “natural” cures.
For the full written case file, visit thepharmafiles.substack.com.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com -
In the late 1950s, thalidomide was marketed as a gentle, “safe” sedative—even for pregnant women—before it caused one of the most devastating drug tragedies in modern history. This episode explores how a lack of testing led to thousands of birth defects worldwide, why one FDA reviewer’s insistence on stronger evidence changed the course of U.S. medicine, and how thalidomide ultimately reshaped global drug regulation.
For the full written case file, visit thepharmafiles.substack.com.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com -
In the mid-20th century, the Hoxsey Method promised a natural cure for cancer—and sparked one of the fiercest battles between alternative medicine and the medical establishment. This episode explores how an unproven herbal remedy became a national movement, why patient testimony outweighed evidence, and what the Hoxsey controversy reveals about fear, trust, and the human side of medicine. For the full written case file, visit thepharmafiles.substack.com.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com -
In the mid-20th century, lobotomy was hailed as a revolutionary cure for mental illness—endorsed by Nobel Prizes and embraced by overcrowded institutions desperate for solutions. This episode examines how authority, urgency, and misplaced optimism turned irreversible brain surgery into standard care, and why its quiet victims were ignored long after doubts emerged. For the full written case file, visit thepharmafiles.substack.com.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com -
In the 1970s, Laetrile—an apricot-pit compound rebranded as “Vitamin B17”—promised a natural cancer cure rejected by U.S. medicine. This episode explores how fear, distrust, and persuasive storytelling turned a failed treatment into a movement, long after the science said otherwise. For the full written case file, visit thepharmafiles.substack.com.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com -
A brief introduction to The Pharma Files, a podcast exploring overlooked chapters in medical history.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com
